Learn More


 
MBA Tools
MBA Glossary

 


Alexion Pharmaceuticals, Inc. - ALXN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Alexion Pharmaceuticals, Inc. - SIC # 8731

Ticker Exchange SIC # Website Latest Ticker
ALXN Nasdaq 8731 http://www.alxn.com/ 102.67 Stock Up +2.64

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Alexion Pharmaceuticals, Inc.

Bayer Files Riociguat in Japan - May 21st, 2013 3:50 pm
Yet Another Acquisition for Bayer - May 21st, 2013 7:20 am
Biogen's Hemophilia BLA Accepted - May 20th, 2013 7:40 am
Bayer's Xofigo Cleared in the US - May 16th, 2013 3:15 pm
[$$] Biotech Fund: Many Healthy Returns - May 14th, 2013 4:10 am
Today's 3 Best Stocks - May 10th, 2013 3:15 pm
Cramer: Biotech Makes a Comeback - May 10th, 2013 2:39 pm
Biotech Makes a Comeback - May 10th, 2013 10:52 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter